Canadians Living with Diabetes Get the STAR Treatment
March 29, 2012 08:30 ET
|
Sanofi Canada
LAVAL, QUEBEC--(Marketwire - March 29, 2012) -
Editors Note: There are two photos associated with this press release.
Diabetes management is entering a new era with the...
Diabetes Advocates Offer Assistance in Accurate Reporting in the Media
March 27, 2012 11:17 ET
|
DIABETES ADVOCATES a program of the DIABETES HANDS FOUNDATION
BERKELEY, Calif., March 27, 2012 (GLOBE NEWSWIRE) -- Did you know there are more than five different types of diabetes? If your knowledge of diabetes is defined by what you hear and see on the news or...
ScinoPharm and National Health Research Institutes (NHRI) Announce Jointly Developed Diabetes Drug Approved for Phase I Clinical Trial
March 23, 2012 10:01 ET
|
ScinoPharm
TAIPEI, TAIWAN--(Marketwire - Mar 23, 2012) - ScinoPharm (TWSE1789), a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global...
Boston Therapeutics Is Quoted as BTHE on the OTC Bulletin Board
March 22, 2012 07:00 ET
|
Boston Therapeutics, Inc.
MANCHESTER, NH--(Marketwire - Mar 22, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that the Company's common stock was quoted on...
Acclaimed Cardiologists Blumenthal, Cannon and Yancy Announce 2012 Schedule for CardioCareLive, the World's Largest Online Cardiology Event
March 20, 2012 13:02 ET
|
PlatformQ, the Leader in Live Online Events
NEEDHAM HEIGHTS, Mass., March 20, 2012 (GLOBE NEWSWIRE) -- CardioCareLive, the popular website for live online streaming video cardiology conferences, today announced that course chairs Roger...
Orgenesis Inc. Announces Acceptance of Technology by U.S. Patent Office
March 20, 2012 08:00 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwire - Mar 20, 2012) - Orgenesis Inc. (OTCBB: ORGS) ("Orgenesis" or the "Company"), a development stage company with a novel therapeutic technology to convert a patient's...
Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board
March 02, 2012 17:13 ET
|
Boston Therapeutics, Inc.
MANCHESTER, NH--(Marketwire - Mar 2, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that it has received clearance by FINRA on...
American Heart Association Launches Free-Access Online Journal
February 21, 2012 16:00 ET
|
American Heart Association
News Highlights:
Among findings posted in the inaugural publication of the American Heart Association's online-only, free-access scientific journal:
The NIH Stroke Scale accurately identifies...
PositiveID Achieves Positive Preliminary Results From Diabetes Research Institute Study at the University of Miami
February 13, 2012 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Feb. 13, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today positive...
New Bread Products Do Not Increase Blood Sugar, Even for Adults Suffering From Diabetes
February 07, 2012 09:00 ET
|
Reddy Bread
HOUSTON, TX--(Marketwire - Feb 7, 2012) - After 13 years of medical practice, research and patient feedback, Cardiologist Kota J. Reddy, M.D. has created a line of bread products that are...